News • PhinC Development

PBPK Modeler - Pharmacometrician (M/W)

PhinC Development has an opening position for a pharmacometrician specialized in Physiologically Based Pharmacokinetics (PBPK) modelling

PhinC participated at FDA event: PBPK best practices

We participated at the FDA workshop about the development of Best Practices in Physiologically Based Pharmacokinetic Modeling to Support Clinical Pharmacology Regulatory Decision-Making.

Development of a new intra-articular module

Development of a PBPK model of a molecule to be able to simulate the exposure in the synovial fluid and plasma following an intra-articular administration in adults.

Job offer: Clinical Programmer

PhinC Development is seeking a Clinical Programmer for joining its subsidiary based in Montreal, PhInc. Modeling.

The success of our PBPK symposium 2019

PhinC Development would like to thank you for being part of this special event dedicated to the PBPK and organised jointly with Club Phase 1.

PhInc. Modeling is launched

We are happy to announces the launch of our new subsidiary PhInc. Modeling in Montreal, Canada.

EMA gave a positive opinion about Fexinidazole

We celebrated, together with our colleagues from Drugs for Neglected Diseases initiative - DNDi and partners, the positive opinion given by the European Medicines Agency about Fexinidazole, DNDi’s first “new chemical entity”…

PhinC renews sponsorship to GMP annual symposium

PhinC Development is proud to sponsor and participate in the special event organized by the GMP that will be held in Lyon on 16th to 18th October 2019.